
Identification Properties Safety Data Specifications andamp; Other Information Links Identification CAS Number 155206-00-1 Name Bimatoprost Synonyms (5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-cyclopentyl}-N-ethyl-5-heptenamid (5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-cyclopentyl}-N-ethyl-5-heptenamide (5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-cyclopentyl}-N-éthyl-5-hepténamide (5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-cyclopentyl}-N-ethylhept-5-enamide 5-Heptenamide, 7-cyclopentyl]-N-ethyl-, (5Z)- bimatoprost bimatoprost Bimatoprost bimatoprostum Lumigan биматопрост بيماتوبروست 贝美前列素 (5Z)-7-cyclopentyl]-N-ethylhept-5-enamide (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)-N-ethylhept-5-enamide (Z)-7-cyclopentyl]-N-ethylhept-5-enamide (Z)-7-cyclopentyl]-N-ethyl-hept-5-enamide 155206-00-1 267244-98-4 5-Heptenamide, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (5Z)- 5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1α(Z),2β(1E,3S*),3α,5α))- AGN 192024|LS-181817|Lumigan® Lumigan (TN) Lumigan® Lumigan; Latisse; AGN 192024; bimatoprostum; Lumigan (TN); AC1NSJUW; AGN-192024; UNII-QXS94885MZ MFCD03411999 UNII-QXS94885MZ Molecular Structure SMILES CCNC(=O)CCC/C=CC1(C(1/C=C/(CCc2ccccc2)O)O)O StdInChI InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1 StdInChIKey AQOKCDNYWBIDND-FTOWTWDKSA-N Molecular Formula C25H37NO4 Molecular Weight 415.57 Properties Appearance White powder; very soluble in ethyl alcohol and methyl alcohol and slightly soluble in water. Safety Data Personal Protective Equipment Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter RIDADR NONH for all modes of transport WGK Germany 3 MSDS MSDS of Bimatoprost CAS 155206-00-1 Specifications and Other Information of Our Bimatoprost CAS 155206-00-1 Standard Enterprise standard Certificate GMP Identification Methods HNMR/HPLC Purity 99.5% min Specific Optical Rotation +33.0-+37.0° Heavy Metals 10ppmmax Residue on Ignition 0.1%max Single Impurity 0.1%max Total Impurities 0.5%max Description Bimatoprostophthalmic solution 0.01% and 0.03% is a synthetic prostamide analog with ocular hypotensive activity; is aclear, isotonic,colorless sterile ophthalmic solution with an osmolalityof approximately 290 mOsmol/kg. Adding proportion for reference Bimatoprostophthalmic solution: 0.01% contains Active:bimatoprost 0.1 mg/mL;Preservative:benzalkonium chloride 0.2mg/ml;Inactives: sodium chloride; sodium phosphatedibasic;citric acid;and purified water.Sodium hydroxide and/or hydrochloric acid may be added to adjust pH. The pH during its shelf life ranges from 6.8-7.8. Bimatoprostophthalmic solution: 0.03% contains Active:bimatoprost: 0.3 mg/mL;Preservative:benzalkonium chloride: 0.05 mg/mL;Inactives: sodium chloride; sodium phosphate,dibasic; citric acid;and purified water.Sodium hydroxide and/or hydrochloric acid may be added to adjust pH. The pH during its shelf life rangesfrom 6.8-7.8. Storage Store at the 2-8℃ Application Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. It has also been used and prescribed off-label to lengthen eyelashes. General View of Documents Links This product is developed by our RD company Caming Pharmaceutical Ltd(http://www.caming.com/), and here is the corresponding linkhttp://www.caming.com/bimatoprost-cas-155206-00-1/ Quick Inquiry Fill out our inquiry form and one of our experts will be in touch with you shortly (Please change screen to horizontal for complete browsing if you are checking Watson on your mobile phone).
https://www.watson-int.com/bimatoprost-cas-155206-00-1/
Comments
Post a Comment